Onduo

By Dave Muoio 02:56 pm August 3, 2020
Austin, Texas-based virtual and on-demand care provider Remedy announced Dr. Ronald Dixon as its chief medical officer. Dixon, formerly the head of clinical affairs at Onduo and the president and CEO of Onduo Professionals (its provider staffing group), is expected to draw on his experience to help Remedy build out its virtual chronic care treatment services. “Dr. Dixon’s experience in developing...
By Dave Muoio 02:37 pm June 15, 2020
The American Diabetes Association's 80th Scientific Sessions kicked off this weekend, and a handful of diabetes management device-makers and service providers highlighted new data as part of the virtual clinical conference. Read on for summaries of the studies and findings, as well as links to the online abstracts. Onduo Verily-backed diabetes management service Onduo, which combines a mobile app...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Jonah Comstock 09:49 am January 21, 2020
One of the biggest digital health success stories of the two decades is in the diabetes space, especially the continuous glucose monitor (or CGM). The first CGM was approved by the FDA in 1999, but in the last decade we've seen CGMs become smaller, longer lasting and more comfortable, and we've seen huge strides in datasharing as CGM-phone connectivity went from novelty to commodity.  Dexcom has...
By Dave Muoio 05:01 pm December 13, 2019
It has been a tumultuous week in the realm of digital health partnerships. It started with word of Proteus Digital Health’s floundering business and failed investment round, which reports say was partially driven by cooling relations between the digital pill maker and its longtime patron Otsuka Pharmaceuticals. A few days later, Sanofi announced a company-wide strategy shift that found Onduo, its...
By Dave Muoio 03:48 pm December 10, 2019
Sanofi announced a major strategy shift today that will end the pharma’s diabetes and cardiovascular R&D efforts in favor of a reinvigorated focus on growing its immunology and vaccine businesses. Among the fallout of this new game plan is Onduo, the pharma’s diabetes management joint venture with Verily that the two companies invested $500 million into back in 2016, according to the company’...
By Dave Muoio 03:56 pm December 5, 2019
#Pelotonad. Peloton has found itself in the middle of controversy as a recent television ad released by the company was panned by many as sexist. The roughly 30-second video, in which a husband purchases the connected exercise bike for his wife as a Christmas gift, has generated a backlash consisting of Twitter hashtags, viral parodies and a roughly 10% drop in Peloton’s stock price; however, the...
By Laura Lovett 04:10 pm October 29, 2019
Life insurer John Hancock has unveiled a new wearable program dubbed Aspire aimed at helping its members with diabetes manage the condition. The program was born out of a partnership with Verily and digital diabetes care platform Onduo.  Users of the new platform can access diabetes coaching via Onduo’s virtual clinic. The program also has fiscal rewards. According to the company, members using...
By Dave Muoio 04:03 pm June 10, 2019
On Friday, the American Diabetes Association kicked off its annual conference in San Francisco, where academics, vendors and other stakeholders congregated to unveil new study results and major announcements related to diabetes management. And while MobiHealthNews already put together a roundup featuring an opening salvo of the show’s announcements, the past few days have seen a tidal wave of new...
By Dave Muoio 03:07 pm December 13, 2018
Onduo, a Verily-Sanofi joint venture focused on digitally-driven diabetes management, is looking to further protect its members from foot ulcers and limb loss. Orpyx Medical Technologies’ diabetic foot ulcer sensors for its members. Thanks to a newly announced deal struck between the companies, Orpyx Medical Technologies’ FDA-cleared SurroSense Rx system will be available to “select members” of...